BioRem (CVE:BRM) Stock Price Down 3.1% – Time to Sell?

BioRem Inc. (CVE:BRM) fell 3.1% during trading on Monday . The company traded as low as C$2.44 and last traded at C$2.50. 53,718 shares were traded during trading, an increase of 6% from the average session volume of 50,470 shares. The stock had previously closed at C$2.58.

Analysts Set New Price Targets

Separately, Cormark raised BioRem to a “moderate buy” rating in a report on Tuesday, December 17th.

BioRem Stock Performance

The company has a current ratio of 1.91, a quick ratio of 1.08 and a debt-to-equity ratio of 37.47. The firm has a market cap of C$42.80 million, a price-to-earnings ratio of 8.06 and a beta of 0.85. The stock has a fifty day moving average price of C$2.80 and a 200 day moving average price of C$2.74.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.